Literature DB >> 25499633

Altered fractionation schedules in radiation treatment: a review.

Kamran A Ahmed1, Candace R Correa1, Thomas J Dilling1, Nikhil G Rao1, Ravi Shridhar1, Andy M Trotti1, Richard B Wilder1, Jimmy J Caudell2.   

Abstract

Conventionally fractionated radiotherapy is delivered in 1.8- to 2.0-Gy fractions. With increases in understanding of radiation and tumor biology, various alterations of radiotherapy schedules have been tested in clinical trials and are now regarded by some as standard treatment options. Hyperfractionation is delivered through a greater number of smaller treatment doses. Accelerated fractionation decreases the amount of time over which radiotherapy is delivered typically by increasing the number of treatments per day. Hypofractionation decreases the number of fractions delivered by increasing daily treatment doses. Furthermore, many of these schedules have been tested with concurrent chemotherapy regimens. In this review, we summarize the major clinical studies that have been conducted on altered fractionation in various disease sites.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25499633     DOI: 10.1053/j.seminoncol.2014.09.012

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  12 in total

1.  Proliferation saturation index in an adaptive Bayesian approach to predict patient-specific radiotherapy responses.

Authors:  Enakshi D Sunassee; Dean Tan; Nathan Ji; Renee Brady; Eduardo G Moros; Jimmy J Caudell; Slav Yartsev; Heiko Enderling
Journal:  Int J Radiat Biol       Date:  2019-03-19       Impact factor: 2.694

Review 2.  Integrating nanomedicine into clinical radiotherapy regimens.

Authors:  Allison N DuRoss; Megan J Neufeld; Shushan Rana; Charles R Thomas; Conroy Sun
Journal:  Adv Drug Deliv Rev       Date:  2019-07-04       Impact factor: 15.470

3.  A time-resolved experimental-mathematical model for predicting the response of glioma cells to single-dose radiation therapy.

Authors:  Junyan Liu; David A Hormuth; Tessa Davis; Jianchen Yang; Matthew T McKenna; Angela M Jarrett; Heiko Enderling; Amy Brock; Thomas E Yankeelov
Journal:  Integr Biol (Camb)       Date:  2021-07-08       Impact factor: 3.177

4.  A Drosophila model to investigate the neurotoxic side effects of radiation exposure.

Authors:  Lisa J Sudmeier; Steven P Howard; Barry Ganetzky
Journal:  Dis Model Mech       Date:  2015-07-01       Impact factor: 5.758

5.  Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials.

Authors:  Yingyu Liu; Changgui Kou; Yingying Su; Yangyu Zhang; Yueyue You; Lili Zhang; Mohan Wang; Yingli Fu; Xiaojun Ren; Yanming Yang
Journal:  Onco Targets Ther       Date:  2017-06-13       Impact factor: 4.147

6.  Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis.

Authors:  Yingyu Liu; Changgui Kou; Wei Bai; Xinyu Liu; Yan Song; Lili Zhang; Mohan Wang; Yangyu Zhang; Yueyue You; Yue Yin; Xin Jiang; Ying Xin
Journal:  Onco Targets Ther       Date:  2018-09-04       Impact factor: 4.147

7.  A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation.

Authors:  Sotiris Prokopiou; Eduardo G Moros; Jan Poleszczuk; Jimmy Caudell; Javier F Torres-Roca; Kujtim Latifi; Jae K Lee; Robert Myerson; Louis B Harrison; Heiko Enderling
Journal:  Radiat Oncol       Date:  2015-07-31       Impact factor: 3.481

8.  Altered fractionation short-course radiotherapy for stage II-III rectal cancer: a retrospective study.

Authors:  Hans Geinitz; Carsten Nieder; Lukas Kocik; Christine Track; Johann Feichtinger; Theresa Weingartner; Kurt Spiegl; Barbara Füreder-Kitzmüller; Johanna Kaufmann; Dietmar H Seewald; Reinhold Függer; Andreas Shamiyeh; Andreas L Petzer; David Kiesl; Josef Hammer
Journal:  Radiat Oncol       Date:  2020-05-14       Impact factor: 3.481

9.  Model-Supported Radiotherapy Personalization: In silico Test of Hyper- and Hypo-Fractionation Effects.

Authors:  Antonella Belfatto; Barbara Alicja Jereczek-Fossa; Guido Baroni; Pietro Cerveri
Journal:  Front Physiol       Date:  2018-10-15       Impact factor: 4.566

10.  On the Immunological Consequences of Conventionally Fractionated Radiotherapy.

Authors:  Juan Carlos L Alfonso; Lito A Papaxenopoulou; Pietro Mascheroni; Michael Meyer-Hermann; Haralampos Hatzikirou
Journal:  iScience       Date:  2020-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.